Clinical Trial Update: A Clinical Research of LeY-Targeted CAR-T in Myeloid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for LeY-targeted CAR-T in myeloid malignancies currently in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloid Malignancies

Drugs mentioned

• LeY-targeted CAR-T

Snippet

Sponsor: Southwest Hospital, China | Conditions: Myeloid Malignancies | Phase 1, Phase 2 | Status: UNKNOWN